Nath Bio-Genes (India) (BOM:537291) Debt-to-Equity : 0.18 (As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Nath Bio-Genes (India) Debt-to-Equity?

Nath Bio-Genes (India)'s Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₹1,055 Mil. Nath Bio-Genes (India)'s Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₹49 Mil. Nath Bio-Genes (India)'s Total Stockholders Equity for the quarter that ended in Mar. 2024 was ₹6,099 Mil. Nath Bio-Genes (India)'s debt to equity for the quarter that ended in Mar. 2024 was 0.18.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Nath Bio-Genes (India)'s Debt-to-Equity or its related term are showing as below:

BOM:537291' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.07 Med: 0.18 Max: 0.24
Current: 0.18

During the past 13 years, the highest Debt-to-Equity Ratio of Nath Bio-Genes (India) was 0.24. The lowest was 0.07. And the median was 0.18.

BOM:537291's Debt-to-Equity is ranked better than
67.89% of 218 companies
in the Agriculture industry
Industry Median: 0.36 vs BOM:537291: 0.18

Nath Bio-Genes (India) Debt-to-Equity Historical Data

The historical data trend for Nath Bio-Genes (India)'s Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nath Bio-Genes (India) Debt-to-Equity Chart

Nath Bio-Genes (India) Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Debt-to-Equity

Get a 7-Day Free Trial

0.13

0.16

0.17

0.18

Nath Bio-Genes (India) Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Debt-to-Equity	Get a 7-Day Free Trial															0.18	N/A	0.19	N/A	0.18

Competitive Comparison of Nath Bio-Genes (India)'s Debt-to-Equity

For the Agricultural Inputs subindustry, Nath Bio-Genes (India)'s Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nath Bio-Genes (India)'s Debt-to-Equity Distribution in the Agriculture Industry

For the Agriculture industry and Basic Materials sector, Nath Bio-Genes (India)'s Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Nath Bio-Genes (India)'s Debt-to-Equity falls into.

Nath Bio-Genes (India) Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Nath Bio-Genes (India)'s Debt to Equity Ratio for the fiscal year that ended in Mar. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1054.809	+	48.65)	/	6099.187
	=	0.18

Nath Bio-Genes (India)'s Debt to Equity Ratio for the quarter that ended in Mar. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1054.809	+	48.65)	/	6099.187
	=	0.18

Nath Bio-Genes (India) (BOM:537291) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Nath Bio-Genes (India) Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Nath Bio-Genes (India)'s Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Nath Bio-Genes (India) (BOM:537291) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Agriculture » Nath Bio-Genes (India) Ltd (BOM:537291) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

NATHBIOGEN:India

Address

Nath House, Nath Road, Chhatrapati Sambhajinagar, MH, IND, 431005

Website

https://www.nathbiogenes.com

Nath Bio-Genes (India) Ltd is engaged in the business of production, processing, and marketing of Hybrid and GM seeds. The company has a product range of field crops, vegetable crops, and micronutrient supplements. It has developed products across verticals of cotton, paddy, mustard, maize, okra, tomato, gourds, chili, and crop nutrition supplements. The operating segments of the group are Agriculture activities and Trading activities, of which a majority of revenue is derived from the Agriculture activities segment. Geographically, the group has a business presence in India and other countries, of which key revenue is generated within India.

Nath Bio-Genes (India) (BOM:537291) Headlines

No Headlines